Jennifer Brown

Washington University, Saint Louis Washington University, Saint Louis, St. Louis, MO 
"Jennifer Brown"
Mean distance: 18.27 (cluster 28)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sharma S, Pavlasova G, Seda V, et al. (2020) miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors. Blood
Cherry KE, Elliott EM, Golob EJ, et al. (2020) Strategic encoding and retrieval processes in verbal recall among middle-aged and older adults. The British Journal of Developmental Psychology
Kim HT, Shaughnessy CJ, Rai SC, et al. (2020) Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia. Blood Advances. 4: 4113-4123
Roeker LE, Dreger P, Brown JR, et al. (2020) Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents. Blood Advances. 4: 3977-3989
Haselager MV, Kielbassa K, Ter Burg J, et al. (2020) Changes in Bcl-2 members in response to ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL. Blood
Guièze R, Liu VM, Rosebrock D, et al. (2019) Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies. Cancer Cell
Kim HT, Ahn KW, Hu ZH, et al. (2019) Prognostic score and cytogenetic risk classification for chronic lymphocytic leukemia patients: Center for International Blood and Marrow Transplant Research report. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Davids MS, Brander DM, Kim HT, et al. (2019) Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial. The Lancet. Haematology
Gruber M, Bozic I, Leshchiner I, et al. (2019) Growth dynamics in naturally progressing chronic lymphocytic leukaemia. Nature
Lampson BL, Kim HT, Davids MS, et al. (2019) Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia. Blood Advances. 3: 1167-1174
See more...